carbamazepine
FDA Approved
Description
Carbamazepine is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and neuropathic pain. It works by reducing nerve impulses that cause seizures and pain. It has been used off-label for primary erythermalgia to reduce burning pain episodes.
Indications & Therapeutic Use
epilepsy, trigeminal neuralgia, neuropathic pain, primary erythermalgia
Global Availability (11 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
carbamazepine
| Generic Name | carbamazepine |
| Brands | 1 brand available |
| Active Ingredient | carbamazepine |
| Drug Class | epilepsy |
| Manufacturer | Novartis |
| Dosage Forms | oral tablet 200mg, 400mg; extended-release tablet; oral suspension 100mg/5mL |
| Medical Code | N03AF01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 11 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations12 Validated Nodes